Alzamend Neuro Inc Ordinary Shares ALZN 深 沪
已收盘 12-19 16:00:00 美东时间
2.14
-0.020
-0.93%
华盛通- 最 高2.35
- 今 开2.19
- 成交量 4.30万股
- 最 低 2.00
- 昨 收 2.16
- 总市值 1.99亿
- 52周最高 8.22
- 市盈率 静 --
- 换手率 0.05%
- 52周最低 0.5101
- 委 比 -47.95%
- 总股本 9301.93万
- 历史最高 33.55
- 量 比 1.28
- 振 幅 16.20%
- 历史最低 0.1132
- 每 手 1
- 风险率 0.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alzamend Neuro Q2 EPS $(0.30) Beats $(1.96) Estimate
Alzamend Neuro (NASDAQ:ALZN) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(1.96) by 84.65 percent. This is a 91.69 percent increase over losses of $(3.61) per share from
12-10 06:37
EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants
Alzamend Neuro completed its first Phase 2 trial for AL001, a novel lithium therapy aiming for better brain delivery and safety, reducing the need for drug monitoring.
11-19 20:30
Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule
Alzamend Neuro完成500万美元私募融资，用于支持针对阿兹海默症、双极性情感障碍、抑郁症和创伤后压力症候群的五项临床试验。
06-16 12:00
Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
Alzamend Neuro initiates Phase II trial of AL001, a novel lithium delivery system, to enhance brain targeting and reduce systemic side effects, with top-line data expected by year-end.
05-29 12:00
EXCLUSIVE: Alzamend Neuro To Launch Phase 2 Study For Lead Drug For PTSD Patients In Late 2025 To Assess Lithium Delivery Benefits
Alzamend Neuro plans a Phase 2 trial of AL001 for PTSD in late 2025, aiming for better lithium delivery, improved safety, and reduced systemic side effects.
03-11 19:33
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Shares of Bit Digital, Inc. (NASDAQ:BTBT) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding term sheet with Boosteroid. Bit Digital reported quarterly losses of nine cents per share, which mi...
2024-08-20 18:15
Nvidia, AMD, Alzamend Neuro, Palo Alto Networks, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Monday, major U.S. indices closed in positive territory. The Dow Jones Industrial Average rose 0.6% to finish at 40,896.53, while the S&P 500 gained nearly 1%, closing at 5,608.25. The Nasdaq saw the largest increase, ending the day up almost 1.4% at 17,876.77. These are the top stocks that gaine...
2024-08-20 10:49
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded up 0.37% to 40,809.60 while the NASDAQ rose 0.87% to 17,785.49. The S&P 500 also rose, gaining, 0.64% to 5,589.66. Check This Out: Around $2M Bet On This Health Care Sto...
2024-08-20 02:37
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Nikola Corporation (NASDAQ:NKLA) fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a mixed shelf offering. Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in today’s mid-day session. G...
2024-08-20 01:37
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Monday. The Dow traded up 0.44% to 40,838.25 while the NASDAQ rose 0.18% to 17,663.86. The S&P 500 also rose, gaining, 0.27% to 5,569.39. Check This Out: Around $2M Bet On This Health Care Stoc...
2024-08-20 00:28
